Avalo Therapeutics, Inc.
AVTX
$19.47
$0.020.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 400.28M | 81.99M | 98.34M | 111.62M | 113.26M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.61M | 6.69M | 6.91M | 2.14M | 1.90M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 49.00K | 147.00K | 37.00K | 90.00K | 20.00K |
| Total Current Assets | 407.93M | 88.83M | 105.29M | 113.85M | 115.19M |
|
|
|||||
| Total Current Assets | 407.93M | 88.83M | 105.29M | 113.85M | 115.19M |
| Net Property, Plant & Equipment | 288.00K | 375.00K | 460.00K | 542.00K | 686.00K |
| Long-term Investments | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Goodwill | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 183.00K | 183.00K | 210.00K | 210.00K | 210.00K |
| Total Assets | 490.78M | 99.89M | 116.46M | 125.10M | 126.58M |
|
|
|||||
| Total Accounts Payable | 3.35M | 356.00K | 137.00K | 474.00K | 2.37M |
| Total Accrued Expenses | 7.54M | 10.92M | 12.41M | 6.77M | 5.68M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 242.00K | 328.00K | 392.00K | 438.00K | 482.00K |
| Total Finance Division Other Current Liabilities | 10.00M | -- | -- | 291.00K | 729.00K |
| Total Other Current Liabilities | 10.00M | -- | -- | 291.00K | 729.00K |
| Total Current Liabilities | 21.13M | 11.60M | 12.94M | 7.97M | 9.26M |
|
|
|||||
| Total Current Liabilities | 21.13M | 11.60M | 12.94M | 7.97M | 9.26M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 35.00K | 117.00K | 197.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.99M | 19.97M | 20.43M | 25.46M | 12.55M |
| Total Liabilities | 42.12M | 31.57M | 33.41M | 33.55M | 22.01M |
|
|
|||||
| Common Stock & APIC | 953.75M | 536.48M | 531.50M | 526.31M | 508.79M |
| Retained Earnings | -504.51M | -468.15M | -448.52M | -434.80M | -404.18M |
| Treasury Stock & Other | -583.00K | -6.00K | 68.00K | 41.00K | -34.00K |
| Total Common Equity | 448.66M | 68.32M | 83.05M | 91.55M | 104.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 448.66M | 68.32M | 83.05M | 91.55M | 104.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 448.66M | 68.32M | 83.05M | 91.55M | 104.57M |
|
|
|||||